- Home
- DIBS vs PROK Comparison
DIBS vs PROK Comparison
Compare DIBS & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- PROK
- Stock Information
- Founded
- DIBS 2000
- PROK 2015
- Country
- DIBS United States
- PROK United States
- Employees
- DIBS N/A
- PROK N/A
- Industry
- DIBS Catalog/Specialty Distribution
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DIBS Consumer Discretionary
- PROK Health Care
- Exchange
- DIBS Nasdaq
- PROK Nasdaq
- Market Cap
- DIBS 88.1M
- PROK 85.5M
- IPO Year
- DIBS 2021
- PROK N/A
- Fundamental
- Price
- DIBS $2.74
- PROK $0.61
- Analyst Decision
- DIBS Hold
- PROK Hold
- Analyst Count
- DIBS 1
- PROK 3
- Target Price
- DIBS N/A
- PROK $3.50
- AVG Volume (30 Days)
- DIBS 258.9K
- PROK 1.7M
- Earning Date
- DIBS 08-05-2025
- PROK 08-08-2025
- Dividend Yield
- DIBS N/A
- PROK N/A
- EPS Growth
- DIBS N/A
- PROK N/A
- EPS
- DIBS N/A
- PROK N/A
- Revenue
- DIBS $88,740,000.00
- PROK $306,000.00
- Revenue This Year
- DIBS $3.02
- PROK $54.34
- Revenue Next Year
- DIBS $6.51
- PROK N/A
- P/E Ratio
- DIBS N/A
- PROK N/A
- Revenue Growth
- DIBS 4.93
- PROK N/A
- 52 Week Low
- DIBS $2.30
- PROK $0.46
- 52 Week High
- DIBS $5.00
- PROK $2.59
- Technical
- Relative Strength Index (RSI)
- DIBS 50.44
- PROK 41.90
- Support Level
- DIBS $2.67
- PROK $0.54
- Resistance Level
- DIBS $3.07
- PROK $0.73
- Average True Range (ATR)
- DIBS 0.20
- PROK 0.13
- MACD
- DIBS -0.00
- PROK -0.02
- Stochastic Oscillator
- DIBS 28.85
- PROK 13.85
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.